BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26006729)

  • 1. Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells.
    Gao X; Sprando RL; Yourick JJ
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):43-51. PubMed ID: 26006729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene expression regulation in mouse- and human embryonic stem cell assays during neural differentiation and in response to valproic acid exposure.
    Schulpen SH; Theunissen PT; Pennings JL; Piersma AH
    Reprod Toxicol; 2015 Aug; 56():77-86. PubMed ID: 26072468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse embryonic stem cell adherent cell differentiation and cytotoxicity (ACDC) assay.
    Barrier M; Jeffay S; Nichols HP; Chandler KJ; Hoopes MR; Slentz-Kesler K; Hunter ES
    Reprod Toxicol; 2011 May; 31(4):383-91. PubMed ID: 21296659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic characterization of C57BL/6 mouse embryonic stem cell differentiation and its modulation by developmental toxicants.
    Gao X; Yourick JJ; Sprando RL
    PLoS One; 2014; 9(9):e108510. PubMed ID: 25247782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
    van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse embryonic stem cells irradiated with γ-rays differentiate into cardiomyocytes but with altered contractile properties.
    Rebuzzini P; Fassina L; Mulas F; Bellazzi R; Redi CA; Di Liberto R; Magenes G; Adjaye J; Zuccotti M; Garagna S
    Mutat Res; 2013 Aug; 756(1-2):37-45. PubMed ID: 23792212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-response evaluation by transcriptomics of methylmercury effects on neural differentiation of murine embryonic stem cells.
    Theunissen PT; Pennings JL; Robinson JF; Claessen SM; Kleinjans JC; Piersma AH
    Toxicol Sci; 2011 Aug; 122(2):437-47. PubMed ID: 21613230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling reveals the heterogeneous transcriptional activity of Oct3/4 and its possible interaction with Gli2 in mouse embryonic stem cells.
    Li Y; Drnevich J; Akraiko T; Band M; Li D; Wang F; Matoba R; Tanaka TS
    Genomics; 2013; 102(5-6):456-67. PubMed ID: 24121003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn).
    Theunissen PT; Robinson JF; Pennings JL; de Jong E; Claessen SM; Kleinjans JC; Piersma AH
    Toxicol Sci; 2012 Feb; 125(2):430-8. PubMed ID: 22045034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure.
    Colleoni S; Galli C; Gaspar JA; Meganathan K; Jagtap S; Hescheler J; Sachinidis A; Lazzari G
    Toxicol Sci; 2011 Dec; 124(2):370-7. PubMed ID: 21934132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells.
    van Dartel DA; Pennings JL; van Schooten FJ; Piersma AH
    Toxicol Appl Pharmacol; 2010 Mar; 243(3):420-8. PubMed ID: 20036270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A statistical approach towards the derivation of predictive gene sets for potency ranking of chemicals in the mouse embryonic stem cell test.
    Schulpen SH; Pennings JL; Tonk EC; Piersma AH
    Toxicol Lett; 2014 Mar; 225(3):342-9. PubMed ID: 24480513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic changes in mouse embryonic stem cells exposed to thalidomide during spontaneous differentiation.
    Gao X; Sprando RL; Yourick JJ
    Data Brief; 2015 Sep; 4():199-202. PubMed ID: 26217789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Tox
    Shinde V; Hoelting L; Srinivasan SP; Meisig J; Meganathan K; Jagtap S; Grinberg M; Liebing J; Bluethgen N; Rahnenführer J; Rempel E; Stoeber R; Schildknecht S; Förster S; Godoy P; van Thriel C; Gaspar JA; Hescheler J; Waldmann T; Hengstler JG; Leist M; Sachinidis A
    Arch Toxicol; 2017 Feb; 91(2):839-864. PubMed ID: 27188386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
    van Dartel DA; Piersma AH
    Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells.
    Meganathan K; Jagtap S; Wagh V; Winkler J; Gaspar JA; Hildebrand D; Trusch M; Lehmann K; Hescheler J; Schlüter H; Sachinidis A
    PLoS One; 2012; 7(8):e44228. PubMed ID: 22952932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks.
    Rieswijk L; Lizarraga D; Brauers KJ; Kleinjans JC; van Delft JH
    Mutagenesis; 2014 Jan; 29(1):17-26. PubMed ID: 24280081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
    Holmgren G; Synnergren J; Bogestål Y; Améen C; Åkesson K; Holmgren S; Lindahl A; Sartipy P
    Toxicology; 2015 Feb; 328():102-11. PubMed ID: 25529476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optimized gene set for transcriptomics based neurodevelopmental toxicity prediction in the neural embryonic stem cell test.
    Pennings JL; Theunissen PT; Piersma AH
    Toxicology; 2012 Oct; 300(3):158-67. PubMed ID: 22760166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Pluripotent Stem Cells to Assess Developmental Toxicity in the Osteogenic Lineage.
    Madrid JV; Sera SR; Sparks NRL; Zur Nieden NI
    Methods Mol Biol; 2018; 1797():125-145. PubMed ID: 29896689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.